These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9400452)

  • 21. Is high-dose yohimbine hydrochloride effective in the treatment of mixed-type impotence? A prospective, randomized, controlled double-blind crossover study.
    Kunelius P; Häkkinen J; Lukkarinen O
    Urology; 1997 Mar; 49(3):441-4. PubMed ID: 9123711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed?
    Morales A
    World J Urol; 2001 Aug; 19(4):251-5. PubMed ID: 11550783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial.
    Morales A; Condra M; Owen JA; Surridge DH; Fenemore J; Harris C
    J Urol; 1987 Jun; 137(6):1168-72. PubMed ID: 3295302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yohimbine in the treatment of male erectile dysfunction.
    Ashton AK
    Am J Psychiatry; 1994 Sep; 151(9):1397. PubMed ID: 8067505
    [No Abstract]   [Full Text] [Related]  

  • 25. Vasomax for the treatment of male erectile dysfunction.
    Goldstein I; Carson C; Rosen R; Islam A
    World J Urol; 2001 Feb; 19(1):51-6. PubMed ID: 11289571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erectile response to transurethral alprostadil, prazosin and alprostadil-prazosin combinations.
    Peterson CA; Bennett AH; Hellstrom WJ; Kaiser FE; Morley JE; Nemo KJ; Padma-Nathan H; Place VA; Prendergast JJ; Tam PY; Tanagho EA; Todd LK; Varady JC; Gesundheit N
    J Urol; 1998 May; 159(5):1523-7; discussion 1527-8. PubMed ID: 9554347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic treatment of impotence.
    Malloy TR; Malkowicz B
    Urol Clin North Am; 1987 May; 14(2):297-305. PubMed ID: 2883750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erectile dysfunction.
    O'Leary M;
    Clin Evid; 2002 Dec; (8):872-80. PubMed ID: 15259177
    [No Abstract]   [Full Text] [Related]  

  • 29. Combination therapy for erectile dysfunction: a randomized, double blind, unblinded active-controlled, cross-over study of the pharmacodynamics and safety of combined oral formulations of apomorphine hydrochloride, phentolamine mesylate and papaverine hydrochloride in men with moderate to severe erectile dysfunction.
    Lammers PI; Rubio-Aurioles E; Castell R; Castaneda J; Ponce de Leon R; Hurley D; Lipezker M; Loehr LA; Lowrey F
    Int J Impot Res; 2002 Feb; 14(1):54-9; discussion 60. PubMed ID: 11896479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yohimbine and pentoxifylline in the treatment of erectile dysfunction.
    Nessel MA
    Am J Psychiatry; 1994 Mar; 151(3):453. PubMed ID: 8109665
    [No Abstract]   [Full Text] [Related]  

  • 31. Yohimbine, erectile capacity, and sexual response in men.
    Rowland DL; Kallan K; Slob AK
    Arch Sex Behav; 1997 Feb; 26(1):49-62. PubMed ID: 9015579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.
    Goldstein I
    Int J Impot Res; 2000 Mar; 12 Suppl 1():S75-80. PubMed ID: 10845768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Double-blind trial of yohimbine in treatment of psychogenic impotence.
    Reid K; Surridge DH; Morales A; Condra M; Harris C; Owen J; Fenemore J
    Lancet; 1987 Aug; 2(8556):421-3. PubMed ID: 2887726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind multicenter study comparing alprostadil alpha-cyclodextrin with moxisylyte chlorhydrate in patients with chronic erectile dysfunction.
    Buvat J; Costa P; Morlier D; Lecocq B; Stegmann B; Albrecht D
    J Urol; 1998 Jan; 159(1):116-9. PubMed ID: 9400450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine.
    Jacobsen FM
    J Clin Psychiatry; 1992 Apr; 53(4):119-22. PubMed ID: 1564046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug therapy of erectile dysfunction--the current status].
    Schultheiss D; Stief CG
    Urologe A; 2003 Oct; 42(10):1322-9. PubMed ID: 14569380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment per os of disorders of erection].
    Giuliano F
    Prog Urol; 1997 Feb; 7(1):108-9. PubMed ID: 9116726
    [No Abstract]   [Full Text] [Related]  

  • 38. [Erectile dysfunctions].
    Riesz P; Nyírády P; Rusz A
    Orv Hetil; 2009 Jan; 150(3):133-5. PubMed ID: 19129149
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis and treatment of psychogenic erectile dysfunction in a urological setting: outcomes of 18 consecutive patients.
    Vickers MA; De Nobrega AM; Dluhy RG
    J Urol; 1993 May; 149(5 Pt 2):1258-61. PubMed ID: 8479009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yohimbine in the treatment of orgasmic dysfunction.
    Adeniyi AA; Brindley GS; Pryor JP; Ralph DJ
    Asian J Androl; 2007 May; 9(3):403-7. PubMed ID: 17486282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.